TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has issued an announcement.
Jubilant Pharmova Limited has announced the publication of its unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2025. These results, approved by the Board of Directors, are accessible to investors through newspaper publications and the company’s website, reflecting the company’s commitment to transparency and regulatory compliance.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company is known for its emphasis on innovation and quality, catering to both domestic and international markets.
Average Trading Volume: 8,445
Technical Sentiment Signal: Buy
Current Market Cap: 174.8B INR
Learn more about JUBLPHARMA stock on TipRanks’ Stock Analysis page.